Opinion: Will the newest pill for HIV prevention fuel progress — or profits?
Four decades after the HIV epidemic began, there’s finally hope it might end. Indeed, “Getting…
Category: Pharmaceuticals
Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages
Sanofi, the French drug giant, said Monday that it would spin off a new company…
STAT Plus: New partnership tries to make up for missing drug data in cost-effectiveness analyses
The Institute for Clinical and Economic Review, ICER, a nonprofit that has become a central…
Opinion: Pharmacists, patients are stuck in the middle of a profit-before-all-else pharmacy racket
The news that chaos reigns inside chain pharmacies, putting patients at risk, may have come…
Merck Receives Complete Response Letter from the US FDA for Supplemental Biologics License Applications (sBLAs) for KEYTRUDA® (pembrolizumab) Six-Week Dosing Schedule
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
STAT Plus: Consumer groups and unions try again to block the AbbVie and Allergan merger
A coalition of consumer groups and unions hopes to convince the Federal Trade Commission to…
STAT Plus: Pharmalittle: Coronavirus clinical trials are going slower than hoped; opioid lawsuit payouts may be less than expected
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: FDA calls states’ bluffs on drug importation
For decades, critics of the U.S. drug pricing system have advocated importing drugs from Canada…
ERVEBO® (Ebola Zaire Vaccine, Live) Now Registered in Four African Countries, Within 90 Days of Reference Country Approval and WHO Prequalification
Dateline City: KENILWORTH, N.J. Democratic Republic of the Congo One of the First African Countries…
Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability
In the 21st century, Americans have found it far too easy to be complacent about…
Weight-loss drug to be pulled from market after FDA expresses concerns on cancer risk
The Japanese drug maker Eisai on Thursday said it would withdraw the weight-loss drug Belviq…
Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC)
Dateline City: KENILWORTH, N.J. In Pivotal Phase 3 KEYNOTE-355 Study, KEYTRUDA Plus Chemotherapy Significantly Improved…
Opinion: 10 reasons why health care startups fail
In our roles at MedTech Innovator, a global accelerator for medtech startups, we’ve worked with…
A lottery like no other offers up a cutting-edge medicine — with lives on the line
The lottery that began this week was not about money, or about choosing a school,…
Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results
Dateline City: KENILWORTH, N.J. Fourth-Quarter 2019 Worldwide Sales Were $11.9 Billion, an Increase of 8%;…
Merck to Focus on Key Growth Pillars Through Spinoff of Women’s Health, Trusted Legacy Brands and Biosimilars Products into New Company (“NewCo”)
Dateline City: KENILWORTH, N.J. NewCo to be a Leading Women’s Health Company; Represents Total Revenue…
STAT Plus: Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
FDA Accepts For Review Supplemental New Drug Application (sNDA) for RECARBRIO™ (imipenem, cilastatin, and relebactam) for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)
Dateline City: KENILWORTH, N.J. Filing Receives Priority Review KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as…
Merck Receives Approval for BELSOMRA® (suvorexant) C-IV Label Update to Include Findings from Study of Insomnia in Patients with Mild-to-Moderate Alzheimer’s Disease
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J. — Merck (NYSE: MRK), known as MSD outside the…
.jpg)
Dr. Christine Seidman and Kathy Warden Elected to Merck Board of Directors
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
Opinion: Companies must responsibly manufacture the antimicrobials society needs
In a world challenged by microbes resistant to antibiotics, many medical interventions that rely on…
Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter
Zolgensma, the Novartis gene therapy for infants and the world’s most expensive medicine, continues to…
Opinion: Biotech can — and must — reshape the pricing debate and protect future innovation
The week before the craziness known as J.P. Morgan 2020 began, more than 300 biotech…
Merck Announces Second-Quarter 2020 Dividend
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
STAT Plus: The FDA wants to know how Instagram influencers sway patient views on medicines
In 2015, Kim Kardashian promoted a morning-sickness pill to her millions of followers on social…
STAT Plus: Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
Federal prosecutors this week announced a $145 million settlement with an electronic health records company…
STAT Plus: Pharmalittle: Insulin dominates Democrats’ health agenda in Iowa; FDA studies Instagram influencers
Good morning, everyone. The world is watching China, the new coronavirus, and the outbreak’s spread….
Opinion: ‘Small’ tactics to counter Big Pharma’s influence on medication overload
Money talks in Washington, D.C., and no sector of the economy speaks more loudly than…
FDA Approves Merck’s DIFICID® (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
Martin Shkreli is sued by the FTC and NY attorney general for illegally cornering a market
More than four years after Martin Shkreli incensed Americans by raising the price of a…
STAT Plus: Former Insys executive who dressed as giant fentanyl bottle gets 26-month sentence
A former high-ranking Insys Therapeutics executive who dressed as a giant fentanyl spray bottle in…
Want to know how contentious drug pricing is in Washington? Check the receipts
WASHINGTON — Pfizer, Johnson & Johnson, Merck and the 31 other major drug makers that…
STAT Plus: Many patient groups have deep ties to pharma but fail to disclose backing
Amid ongoing debate over the role the pharmaceutical industry plays in shaping health policy, a…
STAT Plus: Amid a competitor’s struggles, a startup with a fraction of its funding takes on ‘digital pills’
A version of this story appeared in STAT’s Health Tech newsletter. Click here to subscribe….
FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA® (olaparib) in HRR-Mutated Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review
Dateline City: KENILWORTH, N.J. Submission Based on PROfound, the First Phase 3 Trial Evaluating a…
STAT Plus: Pfizer’s big data exec on pharma’s ‘arms race’ to partner with companies like Fitbit, 23AndMe, and others
Pharmaceutical giants are hunting for ways to tap into the data from your smart watch,…
Tweaking how CAR-T therapy kills tumors could stop a dangerous side effect, study finds
As every trauma surgeon knows, there are messy bullet wounds and there are neat ones,…
Listen: A J.P. Morgan recap, a plan to bust pharma monopolies, and a website for cancer patients
Why weren’t there any big deals announced this week? What does the word “equivalar” mean?…
STAT Plus: Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation
WASHINGTON — A Republican member of the Federal Trade Commission on Thursday expressed support for…
Merck Completes Acquisition of ArQule
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
A forerunner in ‘smart pills’ adopts a new tack as key pharma partnership unravels
SAN FRANCISCO — It was supposed to be a showcase for the way in which…
FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA® (olaparib) as First-Line Maintenance with Bevacizumab in Advanced Ovarian Cancer and Grants Priority Review
Dateline City: KENILWORTH, N.J. Submission Based on PAOLA-1 Trial Which Studied LYNPARZA with Bevacizumab in…
STAT Plus: Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for…
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ With or Without Papillary Tumors Who Are Ineligible for or Have Elected Not to Undergo Cystectomy
Dateline City: KENILWORTH, N.J. KEYTRUDA Is the First Anti-PD-1 Therapy Approved for Certain Patients With…
STAT Plus: Pharmalittle: Execs vow to place patients ahead of profits; conservatives like Republican drug pricing bill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Opinion: A new biotechnology and pharmaceutical industry commitment to patients and the public
We,the undersigned leaders in the biotechnology and pharmaceutical industries, academia, and life science investors, recognize…
.jpg)
Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Dateline City: KENILWORTH, N.J. Phase 3 KEYNOTE-604 Study Did Not Meet Other Dual Primary Endpoint…
Merck Establishes Strategic Oncology Collaboration with Taiho and Astex
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
Merck to Hold Fourth-Quarter and Full-Year 2019 Sales and Earnings Conference Call on February 5
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States…
Merck to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…